3rd International Symposium on Alternatives to Antibiotics
Bangkok, ThailandDecember 16-18, 2019
ORAL PRESENTATIONS
- Immunization of broiler chickens against necrotic enteritis: Progress and possibilities
John Prescott, University of Guelph, Canada - The future of Salmonella vaccines in a geographically diverse and changing epidemiological environment
Filip Van Immerseel, University of Ghent, Belgium - Novel vaccine antigens identified by chicken monoclonal antibodies against apicomplexans
Kazumi Sasai, Osaka Prefecture University, Japan - Development of a subunit vaccine targeting Clostridium perfringens enzymes for the control of necrotic enteritis in broilers
Lisa Bielke, The Ohio State University, United States of America - Immunization with recombinant subunit vaccines from virulent Clostridium perfringens field strains confers partial protection against
necrotic enteritis in broiler chickens
Charles Li, BARC/ARS/USDA, United States of America
SESSION 1: VACCINES
- Microbiome for gut health: A modern tool and a target in the effort to address antimicrobial resistance
Tun, Hein Min, University of Hong Kong, Hong Kong - Non-antibiotic strategies to modify the microbial population of dairy cattle: impacts on milk production, animal health and food safety
Todd Callaway, University of Georgia, United States of America - Small molecular weight metabolites regulating growth and immunity as postbiotic antibiotic alternatives
Inkyung Park, USDA-ARS, Korea - Microbiological quality and possible role as a source of antimicrobial resistance genes of commercial probiotic products for livestock
and aquatic animals
Rungtip Chuanchuen, Chulalongkorn University, Thailand - Swine-derived probiotic L. Plantarum modulates porcine intestinal endogenous HDP synthesis
Jing Wang, Beijing Academy of Agriculture, China
SESSION 2: MICROBIAL-DERIVED PRODUCTS
- Strategies to reduce antibiotics in swine production in China
Junjun Wang, China - Non-antibiotic treatments for honey bee diseases in the era of omics
Judy Chen, USDA-ARS, United States of America - In vitro and in vivo characterization of a Gly-substituted DLP4 cationic peptide against Staphylococcus aureus CVCC 546
Bing Li, Chinese Academy of Agricultural Sciences, China - Afterlife of bacterial cell debris: Peptidoglycan in the gastrointestinal tract
Christian Nyffenegger, Novozymes A/S, Denmark - Fighting AMR by optimizing gastrointestinal functionality: A holistic approach
Pietro Celi, DSM, Switzerland - Organic acids as antibiotic alternatives in monogastric animals
Chengbo Yang, University of Manitoba, Canada - 25-OH-D3: An indispensable tool to managing antibiotic free feeding programs for commercial broilers
Thau Kiong Chung, DSM Nutritional Products Asia Pacific, Singapore - Alternatives to Veterinary Antimicrobials (AVANT): A new EU project focused on diarrhoea in pigs
Poul Jesper Baekbo, SEGES, Denmark
SESSION 3: INNOVATIVES DRUGS, CHEMICALS AND ENZYMES
- Sensing and reacting: micronutrients and phytochemicals in gut health
John Furness, University of Melbourne, Australia - Mechanisms of Baitouweng Decoction in the treatment of diarrhea caused by Escherichia coli
Hong Dong, Beijing Key Laboratory of Traditional Chinese Veterinary Medicine, China - An anthocyanin-rich purple potato extracts reduce high fat diet and lipopolysaccharide (LPS) induced obesity and low-grade gut
inflammation
Hua Zhang, Jiangxi University, China - Dietary resistant potato starch alters immunological status and microbial populations in swine to limit Salmonella
Crystal L Loving, USDA-ARS, United States of America - Phytonutrients: The Next Generation
Emma Wall, Full Circle Science, United States of America - Science-based use of plant extracts to improve animal health in post-antibiotic era: where are we?
Prashant Mishra, AVT Natural, Mexico - In-vitro antibacterial activity of phytobiotic against Eschericia coli and Mycoplasma gallisepticum
Elvina Jonas Jahja, PT. MEDION FARMA JAYA, Indonesia - In vitro and in vivo evaluation of therapeutic effects of neutrapathTM against Salmonella Typhimurium
Hongyu Xue, Amlan International, United States of America
SESSION 4: PHYTOCHEMICALS
- Passive Immunity and IgG-like antibodies as an alternative to antibiotics
Peter Heegaard, Technical University of Denmark, Denmark - Host defense peptides with anti-microbial and immunomodulatory activities as antibiotic alternatives
Woohyun Kim, Gyeongsang National University, Korea - Innovative enterobactin-specific egg yolk antibodies for controlling Gram-negative pathogens
Jun Lin, University of Tennessee, United States of America - High throughput screening for natural host defense peptide-inducing compounds as alternatives to antibiotics
Glenn Zhang, Oklahoma State University, United States of America - Making the transition from research trials to field application
Douglas Korver, University of Alberta, Canada - Reprogramming the innate immune system as an alternative
Henk Haagsman, Utrecht University, The Netherland - Efficacy of dried egg product administered to male broiler chickens during experimental necrotic enteritis
Jeffery Escobar, Elanco Animal Health, United States of America - Yeast cell wall immunomodulatory and intestinal integrity effects on broilers challenged with Salmonella Enteritidis
Ekachai Jenwitheesuk, ICC Brazil, Brazil
SESSION 5: IMMUNE-RELATED PRODUCTS
- US FDA’s Regulatory Pathway for Alternatives to Veterinary Antimicrobials
Joshua Hayes, Center for Veterinary Medicine, Food and Drug Administration, United States of America -
Promoting the authorization of alternatives to veterinary medicinal antimicrobials in the European Union
Javier Pozo, European Medicine Agency, Amsterdam, The Netherlands - Legal framework for the approval/designation of alternatives to antibiotics
Takashi Kozasa, Ministry of Agriculture, Forestry and Fisheries, the Government of Japan -
Industry perspective on the registration of alternatives to antibiotics
Erik De Ridder, Health for Animals, Belgium
SESSION 6: REGULATORY PATHWAYS TO ENABLE THE LICENSING OF ALTERNATIVES TO ANTIBIOTICS AND INCENTIVES FROM STAKEHOLDERS TO SUPPORT THEIR DEVELOPMENT